Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ashton Yang"'
Autor:
Ganesh Ram R Visweswaran, Kamalakannan Vijayan, Ramyavardhanee Chandrasekaran, Olesya Trakhimets, Samantha L Brown, Vladimir Vigdorovich, Ashton Yang, Andrew Raappana, Alex Watson, William Selman, Meghan Zuck, Nicholas Dambrauskas, Alexis Kaushansky, D Noah Sather
Publikováno v:
PLoS Pathogens, Vol 18, Iss 7, p e1010671 (2022)
Blocking Plasmodium, the causative agent of malaria, at the asymptomatic pre-erythrocytic stage would abrogate disease pathology and prevent transmission. However, the lack of well-defined features within vaccine-elicited antibody responses that corr
Externí odkaz:
https://doaj.org/article/d95dfd699a3645d69b9a43f8a7667ee8
Autor:
Whitney E. Harrington, Olesya Trakhimets, Daniela V. Andrade, Nicholas Dambrauskas, Andrew Raappana, Yonghou Jiang, John Houck, William Selman, Ashton Yang, Vladimir Vigdorovich, Winnie Yeung, Micaela Haglund, Jackson Wallner, Alyssa Oldroyd, Samantha Hardy, Samuel W.A. Stewart, Ana Gervassi, Wes Van Voorhis, Lisa Frenkel, D. Noah Sather
Publikováno v:
Cell Reports Medicine, Vol 2, Iss 4, Pp 100253- (2021)
Summary: The fate of protective immunity following mild severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection remains ill defined. Here, we characterize antibody responses in a cohort of participants recovered from mild SARS-CoV-2 in
Externí odkaz:
https://doaj.org/article/60c45fb8b96640d78d452e501895eabe
Autor:
Winnie Yeung, Whitney E. Harrington, Vladimir Vigdorovich, William Selman, Ashton Yang, D. Noah Sather, John Houck, Samuel W.A. Stewart, Alyssa Oldroyd, Wes Van Voorhis, Lisa M. Frenkel, Jackson Wallner, Olesya Trakhimets, Ana Gervassi, Nicholas Dambrauskas, Andrew Raappana, Daniela V. Andrade, Samantha Hardy, Yonghou Jiang, Micaela Haglund
Publikováno v:
Cell Reports Medicine, Vol 2, Iss 4, Pp 100253-(2021)
Cell Reports Medicine
Cell Reports Medicine
The fate of protective immunity following mild SARS-CoV-2 infection remains ill defined. Here we characterize antibody responses in a cohort of participants recovered from mild SARS-CoV-2 infection with follow up to 6 months. We measure IgA, IgM, and